Antineutrophil cytoplasmic autoantibodies: How are they detected and what is their use for diagnosis, classification and follow-up?

Clinical Reviews in Allergy and Immunology

Volumn 43, Issue 3, 2012, Pages 211-219

  Tervaert, Jan Willem Cohen ^a   Damoiseaux, Jan ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ANCA; Classification; Glomerulonephritis; MPO ANCA; PR3 ANCA; Vasculitis

Indexed keywords

MONOCLONAL ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHURG STRAUSS SYNDROME; DISEASE ACTIVITY; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GLOMERULONEPHRITIS; HUMAN; IMMUNOFLUORESCENCE; MICROSCOPIC POLYANGIITIS; NECROTIZING CRESCENTIC GLOMERULONEPHRITIS; PROGNOSIS; WEGENER GRANULOMATOSIS;

ANIMALS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MYELOBLASTIN; PEROXIDASE;

EID: 84871641115     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-012-8320-4     Document Type: Article

References (88)

1. Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187-192 (Pubitemid 24065492)
2. Hilhorst M, van Paassen P, van Breda VP, Cohen Tervaert JW (2011) Immune complexes in acute adult-onset Henoch-Schonlein nephritis. Nephrol Dial Transplant 26:3960-3967
3. Haas M, Eustace JA (2004) Immune complex deposits in ANCAassociated crescentic glomerulonephritis: a study of 126 cases. Kidney Int 65:2145-2152 (Pubitemid 38670000)
4. Brons RH, de Jong MC, de Boer NK, Stegeman CA, Kallenberg CG, Tervaert JW (2001) Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis. Ann Rheum Dis 60:1097-1102 (Pubitemid 33096073)
5. Tervaert JW, Heeringa P (2003) Pathophysiology of ANCAassociated vasculitides: are ANCA really pathogenic? Neth J Med 61:404-407
6. Tervaert JW, Elema JD, Kallenberg CG (1990) Clinical and histopathological association of 29kD-ANCA and MPO-ANCA. APMIS Suppl 19:35
7. Tervaert JW, Limburg PC, Elema JD et al (1991) Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis. Am J Med 91:59-66
8. Lyons PA, Rayner TF, Trivedi S, et al. (2012) Genetically distinct subsets within ANCA-Associated vasculitis. New Engl J Med (in press
9. Franssen CF, Stegeman CA, Kallenberg CG et al (2000) Antiproteinase 3-And antimyeloperoxidase-Associated vasculitis. Kidney Int 57:2195-2206
10. Tervaert JW (2003) ANCA testing in monitoring the activity of the disease. Kidney Blood Press Res 26:226-230 (Pubitemid 37176864)
11. Sinico RA, Di Toma L, Maggiore U et al (2005) Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 52:2926-2935 (Pubitemid 41369124)
12. Dennert RM, van Paassen P, Schalla S et al (2010) Cardiac involvement in Churg-Strauss syndrome. Arthritis Rheum 62:627-634
13. Nölle B, Specks U, Lüdemann J, Rohrbach MS, DeRemee RA, Gross WL (1989) Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med 111:28-40 (Pubitemid 19167594)
14. Holle JU, Gross WL, Holl-Ulrich K et al (2010) Prospective longterm follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage? Ann Rheum Dis 69:1934-1939
15. Wilde B, van Paassen P, Witzke O, Tervaert JW (2011) New pathophysiological insights and treatment of ANCA-Associated vasculitis. Kidney Int 79:599-612
16. Cohen Tervaert JW (2011) Rituximab in ANCA-Associated vasculitis: a revolution? Nephrol Dial Transplant 26:3077-3079
17. Damoiseaux J, Cohen Tervaert JW (2005) Tests for autoantibodies. In: Vohr H (ed) Encyclopedic reference of immunotoxicology. Springer-Verlag, Heidelberg, pp 68-72
18. Boomsma MM, Damoiseaux JGMC, Stegeman CA, Kallenberg CGM, Patnaik M, Peter JB, Cohen Tervaert JW (2003) Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis. J Immunol Methods 274:27-35 (Pubitemid 36263040)
19. Savige J, Gillis D, Benson E et al (1999) International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 111:507-513 (Pubitemid 29153147)
20. Rutgers A, Damoiseaux JG, Roozendaal C, Limburg PC, Stegeman CA, Cohen Tervaert JW (2004) ANCA-GBM dot-blot: evaluation of an assay in the differential diagnosis of patients presenting with rapidly progressive glomerulonephritis. J Clin Immunol 24:435-404
21. Damoiseaux J, Vaessen M, Knapen Y, Csernok E, Stegeman CA, Van Paassen P, Cohen Tervaert JW (2007) Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-Associated vasculitis and Goodpasture's disease. Ann N Y Acad Sci 1109:454-463 (Pubitemid 47511388)
22. Damoiseaux JG, Slot MC, Vaessen M, Stegeman CA, Van Paassen P, Cohen Tervaert JW (2005) Evaluation of a new fluorescentenzyme immuno-Assay for diagnosis and follow-up of ANCAassociated vasculitis. J Clin Immunol 25:202-208 (Pubitemid 40884045)
23. Mahler M, Radice A, Yang W et al (2012) Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies. Clin Chim Acta 413:719-726
24. Goldschmeding R, Vanderschoot CE, Tervaert JWC, Mason DY, Von dem Borne AEGK, Kallenberg CGM (1988) Autoantibodies against myeloid lysosomal-enzymes -A novel class of autoantibodies associated with vasculitic syndromes. Kidney Int 34:558-559
25. Cohen Tervaert JW, Goldschmeding R, Elema JD, Van der Giessen M, Huitema MG, Van der Hem GK, The TH, Von dem Borne AE, Kallenberg CG (1990) Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int 37:799-806 (Pubitemid 20056854)
26. Tervaert JW, Goldschmeding R, Elema JD et al (1990) Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum 33:1264-1272 (Pubitemid 20273316)
27. Cohen Tervaert JW, Mulder L, Stegeman CA, Elema J, Huitema M, The H, Kallenberg CG (1993) Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders. Ann Rheum Dis 52:115-120 (Pubitemid 23065670)
28. Csernok E, Holle J, Hellmich B et al (2004) Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study. Rheumatology (Oxford) 43:174-180 (Pubitemid 38219671)
29. Boomsma MM, Stegeman CA, Oost-Kort WWet al (2001) Native and recombinant proteins to analyze auto-Antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis. J Immunol Methods 254:47-58 (Pubitemid 32530747)
30. Westman KW, Selga D, Isberg PE, Bladström A, Olsson H (2003) High proteinase 3-Anti-neutrophil cytoplasmic antibody (ANCA), level measured by the capture enzyme-linked immunosorbent assay method is associated with decreased patient survival in ANCAassociated vasculitis with renal involvement. J Am Soc Nephrol 14:2926-2933 (Pubitemid 37305655)
31. Westman KW, Selga D, Bygren P et al (1998) Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody. Kidney Int 53:1230-1236 (Pubitemid 28316883)
32. Arranz O, Ara J, Rodriguez R et al (2001) Comparison of anti-PR3 capture and anti-PR3 direct ELISA for detection of antineutrophil cytoplasmic antibodies (ANCA) in long-Term clinical follow-up of PR3-ANCA-Associated vasculitis patients. Clin Nephrol 56:295-301 (Pubitemid 32923163)
33. Gisslén K, Wieslander J, Westberg G, Herlitz H (2002) Relationship between anti-neutrophil cytoplasmic antibody determined with conventional binding and the capture assay, and long-Term clinical course in vasculitis. J Intern Med 251:129-135 (Pubitemid 34146695)
34. Segelmark M, Westman K, Wieslander J (2000) How and why should we detect ANCA? Clin Exp Rheumatol 18:629-635
35. Van Der Geld YM, Limburg PC, Kallenberg CG (1999) Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies. Clin Exp Immunol 118:487-496
36. Homma T, Suzuki K, Kudo Y et al (1989) Preparation and characterization of monoclonal antibodies against human myeloperoxidase. Arch Biochem Biophys 273:189-196 (Pubitemid 19197906)
37. Lee AS, Finkielman JD, Peikert T, Hummel AM, Viss MA, Specks U (2005) A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-Terminally tagged recombinant neutrophil serine proteases. J Immunol Methods 307:62-72 (Pubitemid 41817267)
38. Roggenbuck D, Buettner T, Hoffmann L, Schmechta H, Reinhold D, Conrad K (2009) High-sensitivity detection of autoantibodies against proteinase-3 by a novel third-generation enzyme-linked immunosorbent assay. Ann N Y Acad Sci 1173:41-46
39. Hellmich B, Csernok E, Fredenhagen G, Gross WL (2007) A novel high sensitivity ELISA for detection of anti-neutrophil cytoplasm antibodies against proteinase-3. Clin Exp Rheumatol 25 (S44):S1-S5 (Pubitemid 46656585)
40. Damoiseaux J, Dähnrich C, Rosemann A et al (2009) A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibodyassociated vasculitis. Ann Rheum Dis 68:228-233
41. Holle JU, Csernok E, Fredenhagen G, Backes M, Bremer JP, Gross WL (2010) Clinical evaluation of hsPR3-ANCA ELISA for detection of antineutrophil cytoplasmatic antibodies directed against proteinase 3. Ann Rheum Dis 69:468-469
42. Westman KW, Bygren PG, Eilert I, Wiik A, Wieslander J (1997) Rapid screening assay for anti-GBM antibody and ANCAs: an important tool for the differential diagnosis of pulmonary renal syndromes. Nephrol Dial Transplant 12:1863-1868 (Pubitemid 27379458)
43. Milovanceva-Popovska M, Grcevska L, Dzikova S et al (2006) ANCA-GBM dot-blot test in diagnosis of patients with glomerulonephritis. Prilozi 27:45-55
44. Damoiseaux J, Steller U, Buschtez M et al (2009) EUROPLUS™ ANCA BIOCHIP mosaic: PR3 and MPO antigen microdots improve the laboratory diagnostics of ANCA-Associated vasculitis. J Immunol Methods 348:67-73
45. Ntatsaki E, Watts RA, Scott DG (2010) Epidemiology of ANCAassociated vasculitis. Rheum Dis Clin North Am 36:447-461
46. Fujimoto S,Watts RA, Kobayashi S et al (2011) Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-Associated vasculitis between Japan and the UK. Rheumatology (Oxford) 50:1916-1920
47. Chen M, Cui Z, Zhao MH (2010) ANCA-Associated vasculitis and anti-GBM disease: the experience in China. Nephrol Dial Transplant 25:2062-2065
48. Tervaert JW, Stegeman CA, Kallenberg CG (1998) Silicon exposure and vasculitis. Curr Opin Rheumatol 10:12-17 (Pubitemid 28058510)
49. Gatenby PA, Lucas RM, Engelsen O, Ponsonby AL, Clements M (2009) Antineutrophil cytoplasmic antibody-Associated vasculitides: could geographic patterns be explained by ambient ultraviolet radiation? Arthritis Rheum 61:1417-1424
50. Chen M, Yu F, Zhang Y, Zou WZ, Zhao MH, Wang HY (2005) Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies. Kidney Int 68:2225-2229 (Pubitemid 43117797)
51. Tervaert JWC, Goldschmeding R, Hene RJ, Kallenberg CGM (1989) Neutrophil cytoplasmic autoantibodies and Wegener's granulomatosis. Lancet 333:270
52. Finkielman JD, Lee AS, Hummel AM et al (2007) ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis. Am J Med 120(643.e9):643.e14
53. Tervaert JW, Goldschmeding R, Elema JD, von dem Borne AE, Kallenberg CG (1991) Anti-myeloperoxidase antibodies in Churg-Strauss syndrome. Thorax 46:70-71
54. Guillevin L, Durand-Gasselin B, Cevallos R et al (1999) Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42:421-430 (Pubitemid 29136088)
55. Dolman KM, Gans RO, Vervaat TJ et al (1993) Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 342:651-652 (Pubitemid 23271506)
56. Slot MC, Links TP, Stegeman CA, Tervaert JW (2005) Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: a long-Term follow-up study. Arthritis Rheum 53:108-113 (Pubitemid 40216359)
57. Gao Y, Chen M, Ye H, Guo XH, Zhao MH, Wang HY (2007) The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil. Int Immunopharmacol 7:55-60 (Pubitemid 44856387)
58. Wiesner O, Russell KA, Lee AS et al (2004) Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum 50:2954-2965 (Pubitemid 39209534)
59. Tervaert JW, Stegeman CA (2004) A difficult diagnosis. Lancet 364:1313-1314
60. McGrath MM, Isakova T, Rennke HG, Mottola AM, Laliberte KA, Niles JL (2011) Contaminated cocaine and antineutrophil cytoplasmic antibody-Associated disease. Clin J Am Soc Nephrol 6:2799-2805
61. Kain R, Exner M, Brandes R et al (2008) Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 14:1088-1096
62. Kawakami T, Takeuchi S, Arimura Y, Soma Y (2012) Elevated anti-lysosomal-Associated membrane protein-2 antibody levels in patients with adult Henoch-Schönlein purpura. Br J Dermatol. doi:10.1111/j.1365-2133. 2012.10884.x
63. Kallenberg CG, Mulder AH, Tervaert JW (1992) Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med 93:675-682
64. Teegen B, Niemann S, Probst C, Schlumberger W, Stöcker W, Komorowski L (2009) DNA-bound lactoferrin is the major target for antineutrophil perinuclear cytoplasmic antibodies in ulcerative colitis. Ann N Y Acad Sci 1173:161-165
65. Tervaert JW, Mulder AH, Horst G, Haagsma EB, Kleibeuker JH, Kallenberg CG (1992) Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases. Gastroenterology 102:1090-1091
66. Peen E, Almer S, Bodemar G et al (1993) Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease. Gut 34:56-62 (Pubitemid 23015951)
67. Carlsson M, Shukla S, Petersson AC, Segelmark M, Hellmark T (2011) Pseudomonas aeruginosa in cystic fibrosis: pyocyanin negative strains are associated with BPI-ANCA and progressive lung disease. J Cyst Fibros 10:265-271
68. Choi HK, Lamprecht P, Niles JL, Gross WL, Merkel PA (2000) Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies. Arthritis Rheum 43:226-231 (Pubitemid 30368232)
69. Slot MC, Tervaert JW, Boomsma MM, Stegeman CA (2004) Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis. Arthritis Rheum 51:269-273 (Pubitemid 38468713)
70. Heeringa P, Huugen D, Tervaert JW (2005) Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection? Trends Immunol 26:561-564 (Pubitemid 41726442)
71. Little MA, Al-Ani B, Ren S et al (2012) Anti-proteinase 3 antineutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system. PLoS One 7(1): e28626
72. Huugen D, Xiao H, van Esch A et al (2005) Aggravation of antimyeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-Alpha. Am J Pathol 167:47-58 (Pubitemid 40884769)
73. Stegeman CA, Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CG (1994) Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 120:12-17 (Pubitemid 24011495)
74. Tomasson G, Grayson PC, Mahr AD, Lavalley M, Merkel PA (2012) Value of ANCA measurements during remission to predict a relapse of ANCA-Associated vasculitis -A meta-Analysis. Rheumatology (Oxford) 51:100-109
75. Franssen CF, Stegeman CA, Oost-Kort WWet al (1998) Determinants of renal outcome in anti-myeloperoxidase-Associated necrotizing crescentic glomerulonephritis. J Am Soc Nephrol 9:1915-1923
76. Jayne D, Rasmussen N, Andrassy K et al (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349:36-44 (Pubitemid 36765101)
77. Sanders JS, Huitma MG, Kallenberg CG, Stegeman CA (2006) Prediction of relapses in PR3-ANCA-Associated vasculitis by assessing responses of ANCA titres to treatment. Rheumatology (Oxford) 45:724-729 (Pubitemid 43985341)
78. Tervaert JW, van der Woude FJ, Fauci AS et al (1989) Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 149:2461-2465 (Pubitemid 19283202)
79. Tervaert JW, Huitema MG, Hené RJ et al (1990) Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 336:709-711 (Pubitemid 20309129)
80. Boomsma MM, Stegeman CA, van der Leij MJ et al (2000) Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum 43:2025-2033
81. Finkielman JD, Merkel PA, Schroeder D et al (2007) Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis. Ann Intern Med 147:611-619 (Pubitemid 351664480)
82. Cartin-Ceba R, Fervenza FC, Specks U (2012) Treatment of antineutrophil cytoplasmic antibody-Associated vasculitis with rituximab. Curr Opin Rheumatol 24:15-23
83. Terrier B, Saadoun D, Sène D et al (2009) Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-Associated vasculitides. Ann Rheum Dis 68:1564-1571
84. Selga D, Segelmark M, Gunnarsson L, Hellmark T (2010) Epitope shift of proteinase-3 anti-neutrophil cytoplasmic antibodies in patients with small vessel vasculitis. Clin Exp Immunol 160:318-324
85. Suzuki K, Kobayashi S, Yamazaki K et al (2007) Analysis of risk epitopes of anti-neutrophil antibody MPO-ANCA in vasculitis in Japanese population. Microbiol Immunol 51:1215-1220
86. Lin W, Chen M, Zhao MH (2009) Follow-up of avidity and titer of anti-myeloperoxidase antibodies in sera from patients with primary ANCA-Associated vasculitis. Autoimmunity 42:198-202
87. Yoshida M, Sasaki M, Nakabayashi I et al (2009) Two types of myeloperoxidase-Antineutrophil cytoplasmic autoantibodies with a high affinity and a low affinity in small vessel vasculitis. Clin Exp Rheumatol 27(Suppl 52):S28-S32
88. Espy C, Morelle W, Kavian N et al (2011) Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's). Arthritis Rheum 63:2105-2115